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Introduction
Idiopathic normal pressure hydrocephalus (INPH) is trea-
ted with cerebrospinal fluid shunting, and ventriculo-
peritoneal shunt (VPS) is the current standard treatment.
The goal of this pooled analysis was to compare the effi-
cacy and safety between VPS and lumbo-peritoneal shunt
(LPS) in patients with INPH specified as disproportionately
enlarged subarachnoid space hydrocephalus (DESH).
Methods
We conducted a multicenter prospective 3-month rando-
mized controlled trial, and then a 1-year extension study,
where all subjects received an LPS with a programmable
valve and were examined periodically for 1 year. Eighty-
three patients with INPH (60 to 85 years old) presenting
with ventriculomegaly, high-convexity and medial subar-
achnoid space tightness in magnetic resonance imaging
were recruited from 20 neurological or neurosurgical cen-
ters in Japan between March 1, 2010 and October 19,
2011. The primary outcome was the modified Rankin
scale (mRS) score 1 year after surgery, and secondary out-
come included the NPH grading scale (NPHGS). The VPS
SINPHONI study was used as a historical control.
Results
The proportion of patients with a favorable outcome (i.e.,
improvement of at least one level in mRS) was 63% (95%
CI: 51-73%), and was comparable to that with VPS
implantation (69%, 95% CI: 59-78%). In NPHGS, the
one-year improvement rate was 75% (95% CI: 64-84%)
and was comparable to that of VPS (77%, 95% CI: 68-
84%). Serious adverse events (SAEs) occurred in 19
patients (22%), 10 of which were related to surgery. SAEs
were more common with LPS than with VPS (15%).
Conclusion
Our results show that LPSs with programmable valves
are effective for treating INPH as an alternative to VPSs.
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